Most physicians adhere to guideline-directed medical therapies for HFrEF based on the 2021 European Society of Cardiology HF guidelines.

The presence or absence of left ventricular hypertrophy may predict the effect of finerenone on heart failure hospitalization risk in patients with CKD and type 2 diabetes.

The heart is a muscle like no other, beating 60 to 100 times per minute on average, around the clock. But when it grows weak, it can lead to serious problems: from debilitating shortness of breath and ...

Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

From the Medical Clinic and Surgical Clinic of the Peter Bent Brigham Hospital, Boston, Mass. Read in part before the Massachusetts Medical Society, at the Clinical Exercises at the Peter Bent ...

Congestive heart ... occur along with heart failure include diabetes, COPD, sleep apnea, and kidney disease. Heart failure may be a chronic condition, and it can impact your life in many ways. Still, ...

When a person reaches stage D heart failure, there are only a few treatment options, such as a heart transplant or a ventricular assist device. Healthcare providers use VADs when treatments are no ...

The centralisation of heart disease treatment in Dhaka has led to an overwhelming burden on institutions like the National Institute of Cardiovascular Diseases (NICVD), resulting in long waiting ...

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously ...

Scientists discovered that blocking the activity of the hormone glucagon could treat a common and challenging type of heart failure that affects millions worldwide. Duke-NUS scientists and their ...

Medically reviewed by Jeffrey S. Lander, MD Medically reviewed by Jeffrey S. Lander, MD Congestive heart failure (CHF) occurs ...